SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 29,394.52 |
| Enterprise Value ($M) | 34,027.62 |
| Book Value ($M) | 15,889.10 |
| Book Value / Share | 109.08 |
| Price / Book | 1.85 |
| NCAV ($M) | -3,806.50 |
| NCAV / Share | -26.13 |
| Price / NCAV | -7.72 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.05 |
| Return on Assets (ROA) | 0.05 |
| Return on Equity (ROE) | 0.08 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.48 |
| Current Ratio | 2.29 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7,108.50 |
| Assets | 26,804.10 |
| Liabilities | 10,915.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 9,835.60 |
| Operating Income | 1,895.00 |
| Net Income | 1,161.10 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 1,547.20 |
| Cash from Investing | -4,101.00 |
| Cash from Financing | 149.30 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock Inc. | 10.10 | 2.81 | |
| 13G/A | Primecap Management Co/ca/ | 11.22 | 3.59 | |
| 13G/A | Vanguard Group Inc | 10.02 | 21.25 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 124,055 | 568,187 | 21.83 | |
| 256,280 | 961,206 | 26.66 | |
| 131,066 | 521,254 | 25.14 | |
| 141,194 | 638,137 | 22.13 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BCRX – BioCryst Pharmaceuticals, Inc. | BDTX – Black Diamond Therapeutics, Inc. |
| BEAM – Beam Therapeutics Inc. | BLUE – bluebird bio, Inc. |
| BMEA – Biomea Fusion, Inc. |
Financial data and stock pages provided by
Fintel.io